The Technical Analyst
Select Language :
BioXcel Therapeutics Inc [BTAI]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

BioXcel Therapeutics Inc Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

BioXcel Therapeutics Inc is listed at the  Exchange

-2.08% $2.82

America/New_York / 28 mar 2024 @ 16:00


BioXcel Therapeutics Inc: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 94.84 mill
EPS: -6.15
P/E: -0.460
Earnings Date: May 06, 2024
SharesOutstanding: 33.63 mill
Avg Daily Volume: 1.584 mill
RATING 2024-03-28
C+
Sell
RATINGS
Rating CashFlow: Strong Sell
Return On Equity: Strong Buy
Return On Asset: Sell
DE: Strong Sell
P/E: Sell
Price To Book: Strong Sell
QUARTER GROWTHS
3/224/221/232/233/234/23
Revenuen/a
Gr.Profitn/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.460 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.08x
Company: PE -0.460 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
$-1.057
(-137.48%) $-3.88
Date: 2024-03-29
Expected Trading Range (DAY)

$ 2.51 - 3.13

( +/- 10.89%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-12-14 Yocca Frank Buy 521 Common Stock
2023-12-14 Yocca Frank Sell 521 Restricted Stock Units
2023-12-14 Mehta Vimal Buy 2 609 Common Stock
2023-12-14 Mehta Vimal Sell 2 609 Restricted Stock Units
2023-12-14 Rodriguez Javier Buy 521 Common Stock
INSIDER POWER
-11.07
Last 81 transactions
Buy: 351 248 | Sell: 440 033

Forecast: 16:00 - $2.82

Live Trading Signals (every 1 min)

Forecast 1: 16:00 - $2.82
Forecast 2: 16:00 - $2.82
Forecast 3: 16:00 - $2.82
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.82 (-2.08% )
Volume 0.336 mill
Avg. Vol. 1.584 mill
% of Avg. Vol 21.21 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for BioXcel Therapeutics Inc

Last 12 Months

Last 12 months chart data with high, low, open and close for BioXcel Therapeutics Inc

RSI

Intraday RSI14 chart for BioXcel Therapeutics Inc

Last 10 Buy & Sell Signals For BTAI

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Feb 8 - 15:35buy$3.74N/AActive
Profile picture for
            BioXcel Therapeutics Inc

BTAI

BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and proprietary machine learning algorithms to identify new therapeutic indices. Its commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. The company also continues to conduct clinical trials evaluating BXCL501 for the treatment of agitation in Alzheimer's disease patients, and for adjunctive treatment of patients with major depressive disorder, as well as in the community for agitation associated with bipolar disorders and schizophrenia. In addition, it is developing BXCL502 as a potential therapy for chronic agitation in dementia; and BXCL701, an investigational, orally administered, systemic innate immunity activator for the treatment of aggressive forms of prostate cancer and advanced solid tumors that are refractory or treatment naïve to checkpoint inhibitors. The company was incorporated in 2017 and is headquartered in New Haven, Connecticut.

Last 10 Buy Signals

Date Signal @
PROPCUSDMar 29 - 11:414.36
GRAILUSDMar 29 - 11:412 214.61
TIMEUSDMar 29 - 11:4032.43
SXPUSDMar 29 - 11:40$0.502
MBOXUSDMar 29 - 11:400.463
LSKUSDMar 29 - 11:40$1.980
ICXUSDMar 29 - 11:41$0.352
ENSUSDMar 29 - 11:4121.89
BTC.BUSDMar 29 - 11:3769 797
THETAUSDMar 29 - 11:39$2.93

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.